SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 379,533 | $9,386,000 | 6.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 1,022,940 | $25,297,000 | 3.79% |
| ASHFORD CAPITAL MANAGEMENT INC | 642,594 | $15,891,000 | 3.27% |
| Ranger Investment Management | 1,491,835 | $36,893,000 | 2.64% |
| AlphaOne Investment Services, LLC | 210,856 | $5,215,000 | 1.71% |
| NORTHPOINTE CAPITAL LLC | 615,061 | $15,210,000 | 1.58% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 141,485 | $3,499,000 | 1.56% |
| FALCON POINT CAPITAL, LLC | 454,002 | $8,989,000 | 1.38% |
| Iguana Healthcare Management, LLC | 300,000 | $7,420,000 | 1.32% |
| KOPP INVESTMENT ADVISORS LLC | 46,839 | $1,158,000 | 1.14% |